SG170063A1 - Aqueous moisturizers and lubricants and uses thereof - Google Patents

Aqueous moisturizers and lubricants and uses thereof

Info

Publication number
SG170063A1
SG170063A1 SG201101510-4A SG2011015104A SG170063A1 SG 170063 A1 SG170063 A1 SG 170063A1 SG 2011015104 A SG2011015104 A SG 2011015104A SG 170063 A1 SG170063 A1 SG 170063A1
Authority
SG
Singapore
Prior art keywords
sperm
compositions
lubricants
moisturizers
relive
Prior art date
Application number
SG201101510-4A
Other languages
English (en)
Inventor
Vibha Gupta
Vineet Gupta
Boris Nikolic
Original Assignee
Aquatrove Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquatrove Biosciences Inc filed Critical Aquatrove Biosciences Inc
Publication of SG170063A1 publication Critical patent/SG170063A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG201101510-4A 2006-03-01 2007-02-28 Aqueous moisturizers and lubricants and uses thereof SG170063A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/364,200 US8703198B2 (en) 2005-03-02 2006-03-01 Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof

Publications (1)

Publication Number Publication Date
SG170063A1 true SG170063A1 (en) 2011-04-29

Family

ID=38461956

Family Applications (2)

Application Number Title Priority Date Filing Date
SG201101510-4A SG170063A1 (en) 2006-03-01 2007-02-28 Aqueous moisturizers and lubricants and uses thereof
SG10201407894PA SG10201407894PA (en) 2006-03-01 2007-02-28 Aqueous moisturizers and lubricants and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201407894PA SG10201407894PA (en) 2006-03-01 2007-02-28 Aqueous moisturizers and lubricants and uses thereof

Country Status (12)

Country Link
US (3) US8703198B2 (pt)
EP (1) EP1996159A2 (pt)
JP (1) JP5507852B2 (pt)
KR (1) KR101490851B1 (pt)
AU (1) AU2007224123A1 (pt)
BR (1) BRPI0708411B1 (pt)
CA (1) CA2644096C (pt)
IL (1) IL193685A (pt)
MX (1) MX2008011187A (pt)
NZ (1) NZ596263A (pt)
SG (2) SG170063A1 (pt)
WO (1) WO2007103194A2 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308234B2 (en) 2012-10-29 2016-04-12 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100233295A1 (en) * 2005-03-02 2010-09-16 Vibha Gupta Aqueous moisturizers and lubricants and uses thereof
US20080193489A1 (en) * 2007-02-13 2008-08-14 Robert De Armond Personal Lubricant Compositions That Are Free Of Glycerin and Parabens
GB0722507D0 (en) * 2007-11-19 2007-12-27 Zhao Xiaobin Hyaluronic acid personal lubricant
CN102438645A (zh) * 2009-01-13 2012-05-02 卢布里斯有限责任公司 阴道上皮界面润滑的治疗调节
GB0905677D0 (en) * 2009-04-01 2009-05-20 Yes Syzygy Ltd Intimate lubrication kit
IT1405998B1 (it) * 2010-12-09 2014-02-06 Bionest Ltd Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato
WO2012092990A2 (de) * 2011-01-05 2012-07-12 Udo Wenske Medizinprodukt zur verbesserung der konzeptionsfähigkeit eines säugetiers
CN103547258B (zh) * 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20140178314A1 (en) * 2012-12-19 2014-06-26 The Procter & Gamble Company Compositions and/or articles with improved solubility of a solid active
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP5904369B2 (ja) * 2012-12-28 2016-04-13 国立大学法人広島大学 精子保存液、精子保存方法及び人工授精方法
MX356046B (es) 2013-03-14 2018-05-03 Church & Dwight Co Inc Composicion lubricante acuosa.
KR101470282B1 (ko) * 2013-10-01 2014-12-05 최원석 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
WO2016018993A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
US10952979B2 (en) 2014-12-19 2021-03-23 Good Clean Love, Inc. Topical fertility promoting product and manufacturing method
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017064482A1 (en) * 2015-10-14 2017-04-20 The Royal Veterinary College Methods and compositions
DE102015121701A1 (de) 2015-12-14 2016-04-07 Ritex GmbH Verwendung von Dimeticon
ITUA20161288A1 (it) * 2016-02-19 2017-08-19 P L Pharma S R L Composizione per favorire la risalita degli spermatozoi nel canale cervico-vaginale umano.
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017176768A1 (en) * 2016-04-04 2017-10-12 Imquest Biosciences, Inc. Low osmolality gel composition
BR112019004971B1 (pt) * 2016-09-22 2021-12-07 Colgate-Palmolive Company Composições de gel hidratante
AU2017362500B2 (en) 2016-11-17 2024-09-26 Renovion, Inc. Treatment of Respiratory Tract Diseases and Infections with Ascorbic Acid Compositions
US20200347347A1 (en) * 2017-10-30 2020-11-05 Premium Genetics [UK] Ltd. Compositions and methods for improved gamete viability and function
WO2019099946A1 (en) 2017-11-17 2019-05-23 Renovion, Inc. Stable ascorbic acid compositions and methods of using the same
KR20200009419A (ko) 2018-07-19 2020-01-30 주식회사 홉앤조이 질 윤활제 조성물
CN109554337B (zh) * 2018-12-24 2022-03-15 内蒙古赛科星家畜种业与繁育生物技术研究院有限公司 透明质酸的用途
US11590073B2 (en) 2020-06-09 2023-02-28 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
EP4014974A1 (en) * 2020-12-17 2022-06-22 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth A composition for use in the treatment of infertility
KR102461196B1 (ko) * 2021-08-24 2022-10-31 주식회사 그리니쉬 정자 활성 효과를 갖는 윤활 조성물
MX2024008001A (es) 2022-01-04 2024-07-12 Renovion Inc Solucion acuosa que comprende una sal de glutation.
WO2024052570A1 (en) * 2022-09-09 2024-03-14 Julius-Maximilians-Universität Würzburg Method for the preservation of functional gametes
CN117258052B (zh) * 2023-11-22 2024-03-01 广州双一乳胶制品有限公司 β-1,3-葡聚糖在制备避孕套用水性润滑剂中的应用

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3719594A (en) * 1971-06-17 1973-03-06 Nat Waterpure Corp Water-softening unit
US4184974A (en) 1974-05-16 1980-01-22 Leuven James W Van Liquid biocidal compositions comprising a mixture of silver ions and sodium pectate
US3965908A (en) 1975-01-02 1976-06-29 Posthuma Albert E Synthetic physiological mucus
US3965906A (en) 1975-02-24 1976-06-29 Colgate-Palmolive Company Absorbent article with pattern and method
US4232003A (en) 1975-11-26 1980-11-04 Posthuma Albert E Synthetic physiological mucus
US4039662A (en) 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4128631A (en) 1977-02-16 1978-12-05 General Mills Chemicals, Inc. Method of imparting lubricity to keratinous substrates and mucous membranes
US4120949A (en) 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4267268A (en) 1979-03-12 1981-05-12 Nelson Jr Robert A Spermatozoa extenders
US4527988A (en) 1982-09-20 1985-07-09 Lutz Peter L Porous contraceptive device with an interstitial liquid
US5209927A (en) * 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
US4670256A (en) 1985-09-23 1987-06-02 V. Valhalla Corp. Vaginal conditioning for sexual activity
DE3765145D1 (de) 1986-03-12 1990-10-31 Euro Celtique Sa Empfaengnisverhuetende zusammensetzung.
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4981686A (en) 1987-05-18 1991-01-01 Hardy Robert E Personal lubricant
US4923699A (en) * 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US5015474A (en) 1988-11-22 1991-05-14 Parnell Pharmaceuticals, Inc. Composition for imparting moisture to a substrate
US5128132A (en) 1988-11-22 1992-07-07 Parnell Pharmaceuticals, Inc. Eriodictyon compositions and methods for treating internal mucous membranes
CA2003198C (en) * 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5013714A (en) 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US5545673A (en) 1989-06-06 1996-08-13 Kelly; Patrick D. Method for reducing risk of infection by sexually transmitted viruses
US5208031A (en) 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
JP2510052B2 (ja) 1989-10-31 1996-06-26 コロンビア ラボラトリーズ インコーポレイテッド 組織与湿組成物及び方法
US5102783A (en) 1990-01-12 1992-04-07 Vetrepharm, Inc. Composition and method for culturing and freezing cells and tissues
US5342617A (en) 1990-12-03 1994-08-30 Medical Polymers, Inc. Water-based human tissue lubricant
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
US5389657A (en) 1993-02-01 1995-02-14 Free Radical Sciences Corporation Method for treating infertility
US6321750B1 (en) 1993-05-03 2001-11-27 Patrick D. Kelly Condom lubricants with zinc salts as anti-viral additives
CA2125060C (en) 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US6200557B1 (en) 1993-07-06 2001-03-13 Perry A. Ratcliff Method of treating HIV by a topical composition
GR940100370A (el) 1993-07-28 1994-07-26 Johnson & Johnson Consumer Products Inc. Μια σπερμοκτονος λιπαντικη αντι-ιου συνθεση και μεθοδος χρησης της.
US5592949A (en) 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
US5895645A (en) 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US5952006A (en) 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
WO1997014785A2 (en) 1995-10-19 1997-04-24 Advanced Reproduction Technologies, Inc. Methods and compositions to improve germ cell and embryo survival and function
US5702218A (en) * 1995-12-13 1997-12-30 Onofrio; Daniel Fastener
US5577514A (en) 1995-12-18 1996-11-26 Zimmerman; Arnold S. Condom
US5879877A (en) 1996-02-09 1999-03-09 Advanced Reproduction Technologies Inc. Use of arabinogalactan in a sperm wash product
US5897987A (en) 1996-03-25 1999-04-27 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
AU714797B2 (en) * 1996-06-14 2000-01-13 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes, methods of making and use thereof
US6596777B1 (en) * 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US5885591A (en) 1996-07-02 1999-03-23 Johnson & Johnson Consumer Products, Inc. Personal lubricant compositions
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US5857959A (en) 1997-02-03 1999-01-12 Veos France Eurl Conception kit
US5899848A (en) 1997-07-14 1999-05-04 Haubrich; Mark A. Device and process for artificial insemination of animals
US6277365B1 (en) * 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
US5902593A (en) 1997-10-01 1999-05-11 Kent; Frances B. Topically applied personal lubricant containing benzalkonium chloride as the active ingredient
DE69919379T2 (de) 1998-11-13 2005-09-08 Continental Projects Ltd. Komplexe von hyaluronic saure/carnitinen und pharmazeutische und kosmetische zusammensetzungen
US6139848A (en) 1999-02-12 2000-10-31 Mcneil-Ppc, Inc. Personal lubricant compositions
US6281251B1 (en) 1999-03-22 2001-08-28 University Of Kentucky Research Foundation Iodo-nonoxynol-9-derivatives and methods for their use
US6231849B1 (en) 1999-03-25 2001-05-15 George A. Schiller Simulated seminal fluid
US6428791B1 (en) 1999-04-13 2002-08-06 Alphamed Pharmace Vticals, Corp Lubrication composition
FR2793495B1 (fr) 1999-05-14 2001-08-10 Imv Technologies Dilueur pour la cryoconservation de spermatozoides de bovins
US6864046B1 (en) 2000-03-01 2005-03-08 Texas Tech University Method for collecting and preserving semen
HU230315B1 (hu) * 2000-03-07 2016-01-28 Rush-Presbyterian-St. Luke's Medical Center Összetételek és eljárások patogén mikrobák és spermatozoák csapdázására
CA2417552C (en) 2000-06-27 2014-05-13 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
US6365200B1 (en) 2000-07-19 2002-04-02 Jason C. Birnholz Topical skin sensitizer
AR035509A1 (es) * 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
EP1480517A4 (en) * 2002-02-07 2007-08-22 Univ Columbia ZINC SALT COMPOSITIONS FOR PREVENTING MOLECULAR BREAST EXTRACTION THROUGH SPERMICIDES AND MICROBICIDES
CA2479222A1 (en) * 2002-03-18 2003-09-25 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
US6610331B1 (en) 2002-05-30 2003-08-26 Scott M. Sweazy Fertility kit
US20050076917A1 (en) 2003-10-10 2005-04-14 Biofilm Ip, Llc. Lubricated condom

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308234B2 (en) 2012-10-29 2016-04-12 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US10406200B2 (en) 2012-10-29 2019-09-10 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucusal tissue disorders
US11058743B2 (en) 2012-10-29 2021-07-13 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US11938166B2 (en) 2012-10-29 2024-03-26 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders

Also Published As

Publication number Publication date
SG10201407894PA (en) 2014-12-30
BRPI0708411B1 (pt) 2023-05-16
JP2009528372A (ja) 2009-08-06
US20140147520A1 (en) 2014-05-29
WO2007103194A3 (en) 2007-11-22
EP1996159A2 (en) 2008-12-03
IL193685A (en) 2016-02-29
CA2644096A1 (en) 2007-09-13
US8703198B2 (en) 2014-04-22
AU2007224123A1 (en) 2007-09-13
KR20090018601A (ko) 2009-02-20
US20060204557A1 (en) 2006-09-14
BRPI0708411A2 (pt) 2011-05-31
CA2644096C (en) 2016-09-06
KR101490851B1 (ko) 2015-02-06
WO2007103194A2 (en) 2007-09-13
JP5507852B2 (ja) 2014-05-28
NZ596263A (en) 2013-05-31
US20150051169A1 (en) 2015-02-19
MX2008011187A (es) 2008-12-18
IL193685A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
SG170063A1 (en) Aqueous moisturizers and lubricants and uses thereof
MX2009000139A (es) Formulaciones pobres en espuma para la proteccion de las plantas.
TW200714294A (en) Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
WO2007126727A3 (en) WATER SOLUBLE β-GLUCAN, GLUCOSAMINE, AND N-ACETYLGLUCOSAMINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
MX2009004435A (es) Tinturas dispersas, su preparacion y su uso.
WO2006000336A3 (de) Anthranilamide als schädlingsbekämpfungsmittel
CR20110470A (es) Proteínas de union a il-17
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
WO2009077471A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
MX2009005313A (es) Uso de productos de proteina vegetal estructurada para producir productos carnicos emulsionados.
WO2011119492A3 (en) Methods and compositions related to the measurement of material properties
TW200716631A (en) Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MX2008002476A (es) Liberacion controlada de gel(es) de aditivos para fluidos funcionales.
MY162640A (en) Thioninium compounds and their use
EP2518150A3 (en) 5'Triphosphate oligonucleotide with blunt end and uses thereof
WO2009111586A3 (en) Autonomous in vitro evolution
MX2009002787A (es) Composiciones y métodos para prevenir el cáncer con cupredoxinas.
MX2010003058A (es) Tintes azo para teñir e imprimir materiales hidrofobicos.
WO2011029008A3 (en) Synbodies to akt1
WO2010099542A3 (en) Formulations of atp and analogas of atp
WO2009047568A3 (en) In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
MX2009008560A (es) Sondas para diagnostico por la imagen.
WO2007039124A3 (en) Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness
WO2011138776A3 (en) Biologic female contraceptives